Alterations in the serum levels of chemokines 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1471-1476

  Ghazanfari, Tooba ^a   Yaraee, Roya ^a   Kariminia, Amina ^b   Ebtekar, Massoumeh ^c   Faghihzadeh, Soghrat ^c   Vaez Mahdavi, Mohammad R ^a   Rezaei, Abbas ^d   Vojgani, Mohammad ^e   Soroush, Mohammad R ^f   Kermani Jalilvand, Arezou ^a   Mohammadi, Parisa ^g   Foroutan, Abbas ^h   Hassan, Zuhair M ^c  

^a SHAHED UNIVERSITY   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^g ALZAHRA UNIVERSITY   (Iran)

^h SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemokines; Fractalkine CX3CL1; IL 8 CXCL8; Inflammatory mediators; Iran; MCP 1 CCL2; Mustard gas; Pulmonary; RANTES CCL5

Indexed keywords

FRACTALKINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MUSTARD GAS; RANTES;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; IRAN; LONG TERM EXPOSURE; LUNG FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CHEMICAL WARFARE AGENTS; CHEMOKINES; COHORT STUDIES; HUMANS; INFLAMMATION MEDIATORS; IRAN; LUNG DISEASES; MUSTARD GAS; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 70449088924     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.022     Document Type: Article

References (46)

1. Balali-Mood M., and Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99 4 (Oct 2006) 273-282
2. Aasted A., Darre E., and Wulf H.C. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 19 4 (Oct 1987) 330-333
3. Ghasemi H., Ghazanfari T., Yaraee R., Soroush M.R., Ghassemi-Broumand M., Pourfarzam S., et al. Systemic and ocular complications of sulfur mustard: a panoramic review. Toxin Rev 28 1 (2009) 14-23
4. Khateri S., Ghanei M., Keshavarz S., Soroush M., and Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 11 (Nov 2003) 1136-1143
5. United Nations Security Council. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Jun. 29, 1987 (1987), United Nations, New York, USA Report No.: S/18953
6. United Nations Security Council. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Jun. 30,1987 (Jul 30 1987), United Nations, New York, USA Report No.: S/19006
7. Moaiedmohseni S., Ghazanfari T., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Long-term health status 20 years after sulfur mustard exposure. Toxin Rev 28 1 (2009) 3-7
8. Ghazanfari T., Faghihzadeh S., Aragizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran cohort study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (Jan 2009) 5-14
9. Ghazanfari Z., Ghazanfari T., Araghizadeh H., Soroush M.R., Yaraee R., Vaez Mahdavi M.R., et al. Physical activity of the civilian chemical victims of Sardasht 20 years after sulfur mustard exposure. Toxin Rev 28 1 (2009) 48-53
10. Emad A., and Emad Y. Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Respir Med 101 4 (Apr 2007) 786-792
11. Shams J., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Hassan Z.M., et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 28 1 (2009) 39-43
12. Calderon T.M., and Berman J.W. Overview and history of chemokines and their receptors. In: Schwlebert L.M. (Ed). Chemokines, Chemokine receptors and Disease in Current Topics in Membranes (2005), Elsevier Inc. 1-47
13. Conti P., and DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 22 3 (2001) 133-137
14. Hollandera C., Sitkauskieneb B., Sakalauskasb R., Westina U., and Janciauskienec S.B. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma. Respir Med 101 (2007) 1947-1956
15. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
16. Mizoue L.S., Sullivan S.K., King D.S., Kledal T.N., Schwartz T.W., Bacon K.B., and Handel T.M. Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine. J Biol Chem 276 36 (2001) 33906-33914
17. Emad A., and Emad V. Elevated levels of MCP-1, MIP-ل and MIP-1â in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis Toxicology. Toxicology 240 (2007) 60-69
18. Emad A., and Emad Y. Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol 27 6 (2007 Nov) 605-612
19. Pourfarzam Sh., Ghazanfari T., Merasizadeh J., Ghanei M., Azimi G., Araghizadeh H., et al. Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Rev 28 1 (2009) 8-13
20. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., and Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci 14 (Jan 1 2009) 540-551
21. Horuk R. Promiscuous drugs as therapeutics for chemokine receptors. Expert Rev Mol Med 11 (Jan 6 2009) e1
22. Farivar A.S., Krishnadasan B., Naidu B.V., and Woolley S.M. The role of the beta chemokines in experimental obliterative bronchiolitis. Exp Mol Pathol 75 (2003) 210-216
23. Ghanei M., Tazelaar H.D., Chilosi M., Harandi A.A., Peyman M., Akbari H.M., et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102 (2008) 825-830
24. Ghanei M., Eshraghi M., Peyman M., Alaeddini F., Jalali A.R., and Sajadi V. Pulmonary function test trend in adult bronchiolitis obliterans. Tanaffos 6 (2007) 40-46
25. Conti P., and DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 22 3 (2001) 133-137
26. Ramm G.A., Shepherd R.W., Hoskins A.C., Greco S.A., Ney A.D., Pereira T.N., et al. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 49 2 (Feb 2009) 533-544
27. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 43 11 (2008) 823-832
28. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214 2 (Jan 2008) 199-210
29. Emad A., and Rezaian G.R. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 112 3 (Sep 1997) 734-738
30. Opalek J.M., Ali N.A., Lobb J.M., Hunter M.G., and Marsh C.B. Alveolar macrophages lack CCR2 expression and do not migrate to CCL2. J Inflamm (Lond) 22 (2007) 4-19
31. Yaraee R., Ghazanfari T., Ebtekar M., Ardestani S.K., Rezaei A., Kariminia A., et al. Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9 (2009) 1466-1470 (this issue)
32. Ghazanfari Z., Ghazanfari T., Kermani-Jalilvand A., Yaraee R., Vaez-Mahdavi M.R., Foroutan A., et al. Association of physical activity and IL-10 levels 20 years after sulfur mustard exposure: Sardasht-Iran cohort study. Int Immunopharmacol 9 (2009) 1504-1508 (this issue)
33. Kono H., and Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 8 4 (Apr 2008) 279-289
34. Reale M., Barbacane R.C., DiGioacchino M., Felaco M., Croce A., Ferro F.M., et al. Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. Immunol Lett 76 (2001) 7-14
35. Struyf S., and De M. I, Scharpe S, Lenaerts JP, Menten P, Wang JM, et al. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur J Immunol 28 4 (Apr 1998) 1262-1271
36. Van D.J., Struyf S., and Opdenakker G. Chemokine-protease interactions in cancer. Semin Cancer Biol 14 3 (Jun 2004) 201-208
37. Saito S., Yamaguchi E., Nakayama H., Miyamoto K., and Kawakami Y. Modulatory roles of RANTES in IL-4 production by human blood CD4+ T cells. CYTOKINE 12 9 (September 2000) 1380-1384
38. Conti P., Reale M., Barbacane R.C., Castellani M.L., and Orso C. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol Lett 80 (2002) 105-111
39. Ko J., Yun C.Y., Lee J.S., Kim D.H., Yuk J.E., and Kim I.S. Differential regulation of CC chemokine receptors by 9-cis retinoic acid in the human mast cell line, HMC-1. Life Sci 79 13 (Aug 22 2006) 1293-1300
40. Balali-Mood M., Hefazi M., Mahmoudi M., Jalali E., Attaran D., Maleki M., et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19 6 (Dec 2005) 713-721
41. Dompeling E., Jobsis Q., Vandevijver N.M.A., Wesseling G., and Hendriks H. Chronic bronchiolitis in a 5-yr-old child after exposure to sulphur mustard gas. Eur Respir J 23 (2004) 343-346
42. Hefazi M., Attaran D., Mahmoudi M., and Balali-Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 17 11 (Oct 2005) 587-592
43. Ghasemi H., Ghazanfari T., Babaei M., Soroush M., Yaraee R., Ghassemi-Broumand M., et al. Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran. Cutan Ocul Toxicol 27 4 (2008 Nov) 317-326
44. Ghanei M., Fathi H., Mohammad M.M., Aslani J., and Nematizadeh F. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 16 8 (2004) 491-495
45. Fudala R., Krupa A., Matthay M.A., Allen T.C., and Kurdowska A.K. Anti-IL-8 autoantibody: IL-8 immune complexes suppress spontaneous apoptosis of neutrophils. Am J Physiol Lung Cell Mol Physiol 293 2 (Aug 2007) L364-L374
46. Tabary O., Miesch M.C., Yvin J.C., Clément A., and Jacquot J. Reduction of chemokine IL-8 and RANTES expression in human bronchial epithelial cells by a sea-water derived saline through inhibited nuclear factor-kappaB activation. Biochem Biophys Res Commun 309 (2003) 310-316